Newsom Vetoes Bill to Cap Insulin Prices, Citing Concerns Over Higher Premiums
-
California Gov. Gavin Newsom vetoed a bill to cap insulin prices at $35 per 30-day supply.
-
The bill would have banned extra costs like deductibles and copays above $35.
-
Newsom said California will soon start making its own low-cost insulin brand called CalRx.
-
Newsom vetoed the bill because he believes capping copays passes costs to consumers through higher premiums.
-
The bill's sponsor criticized Newsom's veto, saying it delays relief for diabetics struggling with high insulin costs.